Quantcast

Latest Oncology Stories

2014-10-20 08:32:12

Latest submission seeks approval for additional blood cancer indication RARITAN, N.J., Oct. 20, 2014 /PRNewswire/ -- Janssen Research & Development, LLC ("Janssen") today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA(®) (ibrutinib) to the U.S. Food and Drug Administration (FDA) by its strategic partner Pharmacyclics, Inc. If approved, this latest regulatory submission will become the fourth indication for IMBRUVICA, adding the treatment of...

2014-10-20 08:31:48

Filing completed just three months after receipt of third FDA approval SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based on data from a Phase 2 study evaluating the use of IMBRUVICA(®) (ibrutinib) in patients with Waldenstrom's macroglobulinemia (WM), which was led by Dr. Steven Treon from the Dana-Farber Cancer...

2014-10-20 08:31:21

Visionary technology leader will architect secure, global solutions to provide insights to Epic's partners about patients' cancer status and therapeutic response via circulating tumor cells SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Epic Sciences announced today the appointment of Michael Giske as chief information officer. Mr. Giske has more than 25 years of defining, designing and implementing secure, global, large-scale technology solutions to deliver innovative and impactful...

2014-10-20 08:30:08

LOS ANGELES, Oct. 20, 2014 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that a paper, titled "A Phase 1b/2 Study of Aldoxorubicin in Patients With Soft Tissue Sarcoma," has been published online in Cancer, the prestigious, peer-reviewed journal of the American Cancer Society. The paper discusses results from CytRx's completed Phase 1b/2 clinical trial where 25 patients were enrolled, including...

2014-10-18 23:00:07

Pink Pajama Party held at local business where all proceeds benefit the fight against breast cancer. New Providence, NJ (PRWEB) October 19, 2014 Stafford Communications, a New Providence-based customer service consulting company, took part in the breast cancer awareness program called “Sleep Pink” on October 20th. Sleep Pink is a national movement of pink pajama parties where women and men can promote awareness and celebrate breast cancer survivors. In support of the program,...

2014-10-17 23:04:38

Hudson Valley fitness boot camp is on a mission to raise funds for breast cancer research. Hudson Valley, NY (PRWEB) October 17, 2014 October is Breast Cancer Awareness Month and Hudson Valley Fit Body Boot Camp, a fitness boot camp located in New Windsor, has launched a variety of events and fundraising efforts to raise awareness, celebrate survival and help raise needed research funds. The fundraising events started with a 14-Day Fat Furnace Program offered at 50% off the normal fitness...

2014-10-17 23:04:14

Top marketplace for toxin-free everyday products embraces Breast Cancer Awareness Month, but alerts consumers to marketing Denver, Colorado (PRWEB) October 17, 2014 Breast Cancer Awareness Month is a big deal at True Goods. The disease still affects far too many women, research needs more investment, treatment options must continue to expand, and it is important for the medical establishment to keep exploring prevention strategies. All of this resonates profoundly at True Goods, where...

2014-10-17 23:00:13

Decisive Health bests 751 entries from around the world at finale event in Austin Austin, Texas (PRWEB) October 17, 2014 Decisive Health’s Treatment Explorer won the LIVESTRONG Foundation’s inaugural Big C competition’s $25,000 grand prize at a finale event Friday night in front of a crowd of 500 supporters and innovators gathered at Austin Music Hall. Headquartered in San Francisco, the patient-centric tool matches cancer patients’ and survivors’ lifestyles with the best...

2014-10-17 12:29:22

Netherlands Cancer Institute (NKI) among first customers BOSTON and LEUVEN, Belgium, Oct. 17, 2014 /PRNewswire/ -- Cartagenia, leader in providing genetics labs and clinicians with software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today the launch of Bench for Oncology, a new software platform that helps pathology labs conduct variant assessment and reporting tasks in the analysis of tumors. Bench for...

2014-10-17 08:25:55

SUNNYVALE, Calif., Oct. 17, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that the European Commission (EC) has granted marketing approval for IMBRUVICA(®) (ibrutinib) throughout the 28 member states of the European Union (EU). IMBRUVICA, a first-in-class, oral, once-daily, non-chemotherapy treatment, now is approved to be marketed in Europe for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.